Thursday, November 02, 2017 5:57:32 AM
https://www.sec.gov/Archives/edgar/data/1614744/000121390017011197/f6k110117ex99-2_kitovpharma.htm
The Company's principal achievements during the past year included:
i. Submitted an NDA to the FDA for KIT-302, which was subsequently filed by the FDA
ii.Signed a definitive License Agreement for KIT-302 for the territory of South Korea with Kuhnil Pharmaceutical Co. Ltd., a leading South Korea-based pharmaceutical company
iii. Received waiver from the FDA for the $2 Million New Drug Application fee for KIT-302
iv. Completed our renal function clinical trial, meeting its primary efficacy endpoint, and also demonstrating that KIT-302 improves renal function
v. Acquired a controlling interest in TyrNovo and subsequently entered into an agreement to acquire an additional 27% of the company
vi. Completed an equity offering for gross proceeds of $3.5 million
vii. Completed a successful preIND discussion with FDA for NT219, a small molecule currently being developed by TyrNovo that presents a new concept in cancer therapy by promoting the degradation of two oncology-related checkpoints, Insulin Receptor Substrates (IRS) 1 and 2, as well as the inhibition of signal transducer and activator of transcription 3 (STAT3)
2018 expected catalysts include:
i. FDA marketing clearance for KIT-302
ii. Additional marketing agreements for the distribution of KIT-302
iii. Complete CMC work on NT219 and begin non clinical work on NT219 towards submitting an IND with the FDA during the first half of 2019
"Importantly, we also enter 2018 in a strong financial position. Our balance sheet was further fortified in the third quarter through our successful follow-on offering. I am pleased to note that there continues to be strong U.S. institutional investor interest in our stock".
EnricoMania
FEATURED POET Announces Design Win and Collaboration with Foxconn Interconnect Technology for High-speed AI Systems • May 14, 2024 10:09 AM
FEATURED Element79 Gold Corp Reports Exceptionally High-Grade Results from Lucero • May 14, 2024 7:00 AM
VAYK Added New Manager for Expansion into $64 Billion Domestic Short-term Rental Market • VAYK • May 14, 2024 9:00 AM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM